Hypertrophic scar is an important clinical problem with limited therapeutic options. Aside from their roles as 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitors, statins have also been demonstrated to decrease scarring by reducing connective tissue growth factor (CTGF) expression. However, poor penetrative ability limits their utility as topical treatments for hypertrophic scar. Here, we aim to develop novel statin formulations using liposomes to enhance dermal penetrative ability and to evaluate their efficacy against formation of hypertrophic scar utilizing our validated rabbit ear hypertrophic scar model. Liposomal simvastatin or pravastatin were compounded using a novel, flexible liposomal formulation and applied topically to rabbit ear hypertrophic scars daily from postoperation day (POD) 14 until POD 25. Scar color, including erythema and melanin, was measured using reflectance spectrophotometry on POD 28, and scar tissue was harvested for evaluation of scar elevation index as well as gene and protein expression. Human foreskin fibroblasts were also treated with statin formulations and CCN2 expression was determined by quantitative PCR. Both simvastatin and pravastatin were efficiently encapsulated in liposomes, forming nanometer‐scale particles possessing highly negative charges. Topical treatment with liposomal simvastatin and pravastatin at 6.5% concentration significantly reduced scar elevation index and decreased type I/III collagen content and myofibroblast persistence in the wound. The erythema/vascularity of scars was reduced by liposomal statin treatment, with concomitant decrease of CD31 expression as measured histologically. Expression levels of transcripts encoding CTGF, collagen I, and collagen III collagen in scar tissue were also decreased by liposomal pravastatin treatment, as were myofibroblast persistence and the type I/III collagen ratio as assessed by immunofluorescence and picrosirus red staining, respectively. Treatment of human foreskin fibroblasts with simvastatin or with liposome‐encapsulated pravastatin resulted in decreased expression of transcript encoding CTGF. Overall, our novel statin formulations encapsulated in liposomes were successfully delivered through topical application, significantly reducing hypertrophic scarring in a rabbit ear model.

No abstract

How to enrich the contents of the " low-carbon eco-city " in the general city planning level , how to the implement the development goals into actions are the major issues of promoting the realization of the goal of low-carbon eco-city by the general city planning . This paper discusses about this, proposes that we should view low-carbon eco-city planning rationally, identifies the impetus of practical low-carbon eco-city planning, and mainly discourses the practical approaches on the compilation level of general low-carbon eco-city planning.

ZnO nanostructures with different morphology have been successfully fabricated by a simple relative low temperature approach at 90 °C for 5 h without surfactant assistance. These structures can be easily tailed using varied concentrations of sodium hydroxide (NaOH) and different amounts of the hydrazine hydrate (N2H4·H2O). X-ray diffraction (XRD) result proves the formation of ZnO with wurtzite structure. Microstructure as revealed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) indicates that the rod-like and chrysanthemum-like ZnO nanostructures contain many radial nanorods, which grow along the [0001] direction. Furthermore, the as-prepared ZnO nanomaterials exhibit high activity on the photo-catalytic degradation of typical persistent organic pollutants (POPs), indicating that they are promising as semiconductor photo-catalysts.